R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, CA Cancer J Clin, vol.66, p.26742998, 2016.

D. Planchard, S. Popat, K. Kerr, S. Novello, E. F. Smit et al., Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, vol.29, p.30285222, 2018.

S. Cox, L. Sloan, J. A. Patten, C. A. Bonner, J. A. Geyer et al., Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer, Psychooncology, vol.11, p.12476429, 2002.

Y. I. Garces, P. Yang, J. Parkinson, X. Zhao, J. A. Wampfler et al., The relationship between cigarette smoking and quality of life after lung cancer diagnosis, Chest, vol.126, p.15596667, 2004.

M. E. Cooley, R. Lundin, and L. Murray, Smoking cessation interventions in cancer care: opportunities for oncology nurses and nurse scientists, Annu Rev Nurs Res, vol.27, p.20192107, 2009.

S. Cox, L. Patten, C. A. Ebbert, J. O. Drews, A. A. Croghan et al., Tobacco use outcomes among patients with lung cancer treated for nicotine dependence, J Clin Oncol Off J Am Soc Clin Oncol, vol.20, p.12177107, 2002.

P. Sardari-nia, J. Weyler, C. Colpaert, P. Vermeulen, E. Van-marck et al., Prognostic value of smoking status in operated non-small cell lung cancer, Lung Cancer Amst Neth, vol.47, p.15713518, 2005.

M. Schmidt-hansen, R. Page, and E. Hasler, The effect of preoperative smoking cessation or preoperative pulmonary rehabilitation on outcomes after lung cancer surgery: a systematic review, Clin Lung Cancer, vol.14, p.23017983, 2013.

S. T. Lugg, T. Tikka, P. J. Agostini, A. Kerr, K. Adams et al., Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery, J Cardiothorac Surg, vol.12, p.28629433, 2017.

M. Hamilton, J. L. Wolf, J. Rusk, S. E. Beard, G. M. Clark et al., Effects of smoking on the pharmacokinetics of erlotinib, Clin Cancer Res Off J Am Assoc Cancer Res, vol.12, pp.2166-2171, 2006.

A. N. Hughes, M. O'brien, W. J. Petty, J. B. Chick, E. Rankin et al., Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers, J Clin Oncol Off J Am Soc Clin Oncol, vol.27, p.19164205, 2009.

E. A. Eisenhauer, P. Therasse, J. Bogaerts, L. H. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer Oxf Engl, vol.45, p.19097774, 1990.

G. M. Blumenthal, S. W. Karuri, H. Zhang, L. Zhang, S. Khozin et al., Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced nonsmall-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses, J Clin Oncol Off J Am Soc Clin Oncol, vol.33, p.25667291, 2015.

K. Nakashima, N. Horita, K. Nagai, S. Manabe, S. Murakami et al., Progression-Free Survival, Response Rate, and Disease Control Rate as Predictors of Overall Survival in Phase III Randomized Controlled Trials Evaluating the First-Line Chemotherapy for Advanced, Locally Advanced, and Recurrent Non-Small Cell Lung Carcinoma, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, vol.11, p.27178983, 2016.

F. De-marinis, J. R. Pereira, F. Fossella, M. C. Perry, M. Reck et al., Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, vol.3, p.18166838, 2008.

, Plasma cotinine and response to chemotherapy in advanced NSCLC

. Plos-one-|, , 2019.

M. Thomas, D. R. Spigel, R. M. Jotte, M. Mccleod, M. A. Socinski et al., nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy, Lung Cancer Auckl NZ, vol.8, p.29138610, 2017.

V. Hirsh, Y. Wan, F. Lin, S. Margunato-debay, T. J. Ong et al., Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin, Clin Lung Cancer, vol.19, p.29903552, 2018.

A. S. Tsao, D. Liu, J. J. Lee, M. Spitz, and W. K. Hong, Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer, Cancer, vol.106, p.16634096, 2006.

R. Duarte, R. R. Luiz, and M. Paschoal, The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients, Lung Cancer Amst Neth, vol.61, p.18243408, 2008.

S. J. Lewis, N. M. Cherry, M. Niven, R. Barber, P. V. Wilde et al., Cotinine levels and self-reported smoking status in patients attending a bronchoscopy clinic, Biomark Biochem Indic Expo Response Susceptibility Chem, vol.8, p.12944174, 2003.

N. A. Morales, M. A. Romano, M. Cummings, K. Marshall, J. R. Hyland et al., Accuracy of self-reported tobacco use in newly diagnosed cancer patients, Cancer Causes Control CCC, vol.24, p.23553611, 2013.

R. Stelmach, F. Fernandes, R. M. Carvalho-pinto, R. A. Athanazio, S. Z. Rached et al., Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth?, J Bras Pneumol Publicacao Of Soc Bras Pneumol E Tisilogia, vol.41, p.25972966, 2015.

N. L. Benowitz, Cotinine as a biomarker of environmental tobacco smoke exposure, Epidemiol Rev, vol.18, p.9021312, 1996.

, Biochemical verification of tobacco use and cessation, Nicotine Tob Res Off J Soc Res Nicotine Tob, vol.4, p.12028847, 2002.

P. Dasgupta, W. Rizwani, S. Pillai, R. Kinkade, M. Kovacs et al., Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines, Int J Cancer, vol.124, p.18844224, 2009.

M. H. Al-wadei, J. Banerjee, A. , H. Schuller, and H. M. , Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling, Eur J Cancer Oxf Engl, vol.52, p.26689865, 1990.

J. Zhang, O. Kamdar, W. Le, G. D. Rosen, and D. Upadhyay, Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer, Am J Respir Cell Mol Biol, vol.40, p.18676776, 2009.

M. Xin and X. Deng, Nicotine inactivation of the proapoptotic function of Bax through phosphorylation, J Biol Chem, vol.280, p.15642728, 2005.

T. Nishioka, L. Luo, L. Shen, H. He, A. Mariyannis et al., Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability, Br J Cancer, vol.110, p.24548862, 2014.

P. Dasgupta, R. Kinkade, B. Joshi, C. Decook, E. Haura et al., Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin, Proc Natl Acad Sci, vol.103, p.16601104, 2006.

E. Giroux-leprieur, T. Vieira, M. Antoine, N. Rozensztajn, N. Rabbe et al., Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma, Clin Lung Cancer, vol.17, p.26762562, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01251414

E. Giroux-leprieur, B. Tolani, H. Li, F. Leguay, N. T. Hoang et al., Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer, Oncotarget, vol.8, p.29262597, 2017.

A. De-graan, W. J. Loos, L. E. Friberg, S. D. Baker, J. M. Van-der-bol et al., Influence of smoking on the pharmacokinetics and toxicity profiles of taxane therapy, Clin Cancer Res Off J Am Assoc Cancer Res, vol.18, p.22645049, 2012.

J. M. Van-der-bol, R. Mathijssen, W. J. Loos, L. E. Friberg, R. Van-schaik et al., Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia, J Clin Oncol Off J Am Soc Clin Oncol, vol.25, p.17563393, 2007.

M. O'malley, P. Healy, S. Daignault, and N. Ramnath, Cigarette smoking and gemcitabine-induced neutropenia in advanced solid tumors, Oncology, vol.85, p.24080957, 2013.

P. G. Shields, Long-term nicotine replacement therapy: cancer risk in context, Cancer Prev Res Phila Pa, vol.4, p.22052338, 2011.